NVET

Nexvet Biopharma plc Ordinary Shares
NVET

Delisted

NVET was delisted on the 28th of July, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Nexvet Biopharma plc Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$17.7M
2
-$7.54M
3
-$5.32M
4
KAM
Kassirer Asset Management
Ontario, Canada
-$803K
5
HCMT
Highland Capital Management (Texas)
Texas
-$702K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
Farallon Capital Management
California
–
BC
2
Broadfin Capital
New York
–
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
–
KAM
4
Kassirer Asset Management
Ontario, Canada
–
HCMT
5
Highland Capital Management (Texas)
Texas
–
GF
6
Gabelli Funds
New York
–
PAMP
7
Polar Asset Management Partners
Ontario, Canada
–
GCIA
8
Gabelli & Co Investment Advisers
New York
–
GP
9
GLG Partners
United Kingdom
–
SMC
10
S. Muoio & Co
New York
–
HM
11
Harvest Management
New York
–
GCL
12
Glazer Capital LLC
New York
–
Norges Bank
13
Norges Bank
Norway
–
DAM
14
DLD Asset Management
New York
–
PCM
15
Prelude Capital Management
New York
–
Deutsche Bank
16
Deutsche Bank
Germany
–
Morgan Stanley
17
Morgan Stanley
New York
–
UBS Group
18
UBS Group
Switzerland
–
FPF
19
FNY Partners Fund
New York
–
Bank of America
20
Bank of America
North Carolina
–